Cita APA (7a ed.)
Krystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003). NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: Toward a paradigm shift in medication development. Psychopharmacology, 169(3/4), 215-216.
Cita Chicago Style (17a ed.)
Krystal, John H., D. Cyril D'Souza, Daniel Mathalon, Edward Perry, Aysenil Belger, y Ralph Hoffman. "NMDA Receptor Antagonist Effects, Cortical Glutamatergic Function, and Schizophrenia: Toward a Paradigm Shift in Medication Development." Psychopharmacology 169, no. 3/4 (2003): 215-216.
Cita MLA (9a ed.)
Krystal, John H., et al. "NMDA Receptor Antagonist Effects, Cortical Glutamatergic Function, and Schizophrenia: Toward a Paradigm Shift in Medication Development." Psychopharmacology, vol. 169, no. 3/4, 2003, pp. 215-216.
Precaución: Estas citas no son 100% exactas.